The Open-label, Proof-of-concept Study of SAGE-547 (Allopregnanolone) in the Treatment of Postpartum Depression

被引：0
|
作者：
Kanes, Stephen J. [1 ]
Colquhoun, Helen [1 ]
Doherty, James [2 ]
Raines, Shane [3 ]
Rubinow, David R. [4 ]
Meltzer-Brody, Samantha [4 ]
机构：
[1] Sage Therapeut, Med Affairs, Cambridge, MA USA
[2] Sage Therapeut, Res & Dev, Cambridge, MA USA
[3] 2b Analyt, Biostat, Wallingford, PA USA
[4] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA
来源：
BIOLOGICAL PSYCHIATRY | 2016年 / 79卷 / 09期
关键词：
allopregnanolone; postpartum depression; antidepressent;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
339
引用
收藏
页码：133S / 133S
页数：1
相关论文
共 50 条
  • [1] Open-label, proof-of-concept study of brexanolone in the treatment of severe postpartum depression
    Kanes, Stephen J.
    Colquhoun, Helen
    Doherty, James
    Raines, Shane
    Hoffmann, Ethan
    Rubinow, David R.
    Meltzer-Brody, Samantha
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2017, 32 (02)
  • [2] SAGE-547 for the Treatment of Severe Postpartum Depression
    Kanes, Stephen
    Colquhoun, Helen
    Gunduz-Bruce, Handan
    Doherty, James
    Jonas, Jeffrey
    Rubinow, David
    Paul, Steven
    Meltzer-Brody, Samantha
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S165 - S166
  • [3] Tocilizumab treatment in patients with Schnitzler syndrome: An open-label proof-of-concept study
    Bonnekoh, H.
    Frischbutter, S.
    Roll, S.
    Maurer, M.
    Krause, K.
    EXPERIMENTAL DERMATOLOGY, 2021, 30 (03) : E21 - E22
  • [4] Lithium efficacy in bipolar depression with flexible dosing: A six-week, open-label, proof-of-concept study
    Machado-Vieira, Rodrigo
    Zanetti, Marcus V.
    De Sousa, Rafael T.
    Soeiro-De-Souza, Marcio G.
    Moreno, Ricardo A.
    Busatto, Geraldo F.
    Gattaz, Wagner F.
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2014, 8 (04) : 1205 - 1208
  • [5] Nocturnal Asthma: Proof-of-Concept Open-Label Study with Delayed-Release Prednisone
    Alavoine L.
    Taillé C.
    Ball J.
    Knauer C.
    Witte S.
    Kent J.
    Aubier M.
    Pulmonary Therapy, 2015, 1 (1) : 43 - 52
  • [6] Trigeminal nerve stimulation (TNS) protocol for treating major depression: An open-label proof-of-concept trial
    Shiozawa, Pedro
    Duailibi, Michel Silvio
    da Silva, Mailu Enokibara
    Cordeiro, Quirino
    EPILEPSY & BEHAVIOR, 2014, 39 : 6 - 9
  • [7] SAFETY AND EFFICACY OF MARALIXIBAT IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS: AN OPEN-LABEL PROOF-OF-CONCEPT STUDY
    Bowlus, Christopher L.
    Eksteen, Bertus
    Cheung, Angela
    Thorburn, Douglas
    Moylan, Cynthia A.
    Pockros, Paul J.
    Forman, Lisa
    Dorenbaum, Alejandro
    Hirschfield, Gideon
    Kennedy, Ciara
    Gu, Joan
    Apostol, George
    Vig, Pamela
    Levy, Cynthia
    HEPATOLOGY, 2019, 70 : 764A - 765A
  • [8] Structured physical exercise for bipolar depression: an open-label, proof-of concept study
    Lafer, Beny
    Duarte, Cicera Claudinea
    Greve, Julia Maria D'Andrea
    Silva, Paulo Roberto dos Santos
    de Almeida, Karla Mathias
    Belizario, Gabriel Okawa
    Neves, Lucas Melo
    INTERNATIONAL JOURNAL OF BIPOLAR DISORDERS, 2023, 11 (01)
  • [9] Structured physical exercise for bipolar depression: an open-label, proof-of concept study
    Beny Lafer
    Cicera Claudinea Duarte
    Julia Maria D’Andrea Greve
    Paulo Roberto dos Santos Silva
    Karla Mathias de Almeida
    Gabriel Okawa Belizario
    Lucas Melo Neves
    International Journal of Bipolar Disorders, 11
  • [10] An open-label, proof-of-concept study of lirentelimab for antihistamine-resistant chronic spontaneous and inducible urticaria
    Altrichter, Sabine
    Staubach, Petra
    Pasha, Malika
    Singh, Bhupinder
    Chang, Alan T.
    Bernstein, Jonathan A.
    Rasmussen, Henrik S.
    Siebenhaar, Frank
    Maurer, Marcus
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (05) : 1683 - +
12345